参考文献/References:
[1] Eisenack M, Umscheid T, Tessarek J, et al. Percutaneous endovascular aortic aneurysm repair: a prospective evaluation of safety, efficiency, and risk factors[J]. J Endovasc Ther, 2009, 16: 708 - 713.
[2] 王志伟, 石海峰, 孙 昊, 等. StarClose血管闭合器在肝脏恶性肿瘤患者经动脉化疗栓塞中的应用[J].介入放射学杂志, 2010, 19: 499 - 501.
[3] Doyle BJ, Godfrey MJ, Lennon RJ, et al. Initial experience with the Cardiva Boomerang vascular closure device in diagnostic catheterization[J]. Catheter Cardiovasc Interv, 2007, 69: 203 - 208.
[4] Jaff MR, Hadley G, Hermiller JB, et al. The safety and efficacy of the starclose vascular closure system: the ultrasound substudy of the CLIP study[J]. Catheter Cardiovasc Intervent, 2006, 68: 684 - 689.
[5] Meyerson SL, Feldman T, Desai TR, et al. Angiographic acess site complications in the era of arterial closure devices[J]. Vasc Endovascular Surg, 2002, 36: 137 - 144.
[6] Wilde NT, Bungay P, Johnson L, et al. Outpatient angioplasty and stenting facilitated by percutaneous arterial suture closure devices [J]. Clin Radiol, 2006, 61: 1035 - 1040.
[7] Rachel ES, Bergamini TM, Kinney EV, et al. Percutaneous endovascular abdominal aortic aneurysm repair [J]. Ann Vasc Surg, 2002, 16: 43 - 49.
[8] Resnic FS, Blake GJ, Ohno-Machadol, et al. Vascular closure devices and the risk of vascular complications after percutaneous coronary intervention in patients receiving glycoprotein Ⅱb-Ⅲa Inhibitors[J]. Am J Cardiol, 2001, 88: 493 - 496.
[9] Meyerson SL, Feldman T, Desai TR, et al. Angiographic access site complications in the era of arterial closure devices[J]. Vasc Endovascular Surg, 2002, 36: 137 - 144.
[10] Koreny M, Riedmüller E, Nikfardjam M, et al. Arterial puncture closing devices compared with standard manual compression after cardiac catheterization: systematic review and meta-analysis[J]. JAMA, 2004, 291: 350 - 357.
[11] Applegate RJ, Grabarczyk MA, Little WC, et al. Vascular closure devices in patients treated with anticoagulation and Ⅱb/Ⅲa receptor inhibitors during percutaneous revascularization[J]. J Am Coll Cardiol, 2002, 40: 78 - 83.
[12] Wagner SC, Gonsalves CF, Eschelman DJ, et al. Complications of a percutaneous suture-mediated closure device versus manual compression for arteriotomy closure: a case-controlled study[J]. J Vasc Interv Radiol, 2003, 14: 735 - 741.
[13] Biancari F, D＇Andrea V, Di Marco C, et al. Meta-analysis of randomized trials on the efficacy of vascular closure devices after diagnostic angiography and angioplasty[J]. Am Heart J, 2010, 159: 518 - 531.
[14] Exaire JE, Dauerman HL, Topol EJ, et al. Triple antiplatelet therapy does not increase femoral access bleeding with vascular closure devices[J]. Am Heart J, 2004, 147: 31 - 34.
[15] Eggebrecht H, von Birgelen C, Naber C, et al. Impact of gender on femoral access complications secondary to application of a collagen-based vascular closure device[J]. J Invasive Cardiol, 2004,16: 247 - 250.
[16] 肖红兵, 张大东, 陈跃光, 等. 血管闭合装置Angioseal和Perclose在股动脉穿刺点封堵中的比较[J]. 介入放射学杂志, 2005, 14: 534 - 536.
[17] Hamner JB, Dubois EJ, Rice TP. Predictors of complications associated with closure devices after transfemoral percutaneous coronary procedures[J]. Crit Care Nurse, 2005, 25: 30 - 37.
[18] Boston US, Panneton JM, Hofer JM, et al. Infectious and isc-hemic complications from percutaneous closure devices used after vascular access[J]. Ann Vasc Surg, 2003, 17: 66 - 71.
[19] Whitton Hollis H Jr, Rehring TF. Femoral endarteritis associated with percutaneous suture closure: new technology, challenging complications[J]. J Vasc Surg, 2003, 38: 83 - 87.
[20] Hoffer EK, Bloch RD. Percutaneous arterial closure devices[J]. J Vasc Interv Radiol, 2003, 14: 865 - 885.
[21] Gemmete JJ, Dasika N, Forauer AR, et al. Successful angio-plasty of a superficial femoral artery stenosis caused by a suture-mediated closure device[J]. Cardiovasc Intervent Radiol, 2003, 26: 410 - 412.
[22] Van der Steeg HJ, Berger P, Krasznai AG, et al. Acute arterial occlusion after deployment of the Angio-Seal closure device: is it as uncommon as we think?[J]. Eur J Vasc Endovasc Surg, 2009, 38: 715 - 717.
[23] Kirchhof C, Schickel S, Schmidt-Lucke C, et al. Local vascular complications after use of the hemostatic puncture closure device Angio-Seal[J]. Vasa, 2002, 31: 101 - 106.
[24] Dregelid E, Jensen G, Daryapeyma A. Complica-tions associated with the Angio-Seal arterial puncture closing device: intra-arterial deployment and occlusion by dissected plaque[J]. J Vasc Surg, 2006, 44: 1357 - 1359.
[25] Gemmete JJ, Dasika N, Forauer AR, et al. Successful angio-plasty of a superficial femoral artery stenosis caused by a suture-mediated closure device[J]. Cardiovasc Intervent Radiol, 2003, 26: 410 - 412.[26] Pontón A, Negueruela CP, Bernal JM, et al. Surgical treatment of arterial ischemia associated with the use of the angioseal vascular closure device[J]. Vasa, 2009, 38: 334 - 337.
[27] Biancari F, Ylonen K, Mosorin M, et al. Lower limb ischemic complications after the use of arterial puncture closure devices [J]. Eur J Vasc Endovasc Surg , 2006, 32: 504 - 505.
[28] Chrisman HB, Liu DM, Bui JT, et al. The safety and efficacy of a percutaneous closure device in patients undergoing uterine artery embolization[J]. J Vasc Interv Radiol, 2005, 16: 347 - 350.